Form 4: Ionis Pharmaceuticals CEO Brett P. Monia Acquires Shares Under Employee Stock Purchase Plan

Ionis Pharmaceuticals CEO Brett P. Monia reports the acquisition of 140 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• On August 30, 2024, Brett P. Monia, CEO of Ionis Pharmaceuticals, acquired 140 shares of Ionis Pharmaceuticals common stock.
• The shares were purchased under the Amended and Restated 2000 Employee Stock Purchase Plan at a price of $38.641 per share.
• Following the transaction, Monia directly owns 174,023 shares of Ionis Pharmaceuticals common stock.
• These shares cannot be sold until February 28, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a routine transaction. The CEO purchasing shares is generally a positive sign, but it's a small amount relative to their holdings.

Positives

• The CEO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Industry Context

Insider transactions are routinely monitored and reported to the SEC. Purchases by executives can be seen as a positive signal, but are also part of standard compensation and investment strategies.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment.

Key Dates